Loading clinical trials...

Impact of Cardiac Rehabilitation on Patient Outcomes | Clinical Trials | Clareo Health

COMPLETEDNA

Impact of Cardiac Rehabilitation on Patient Outcomes

The Impact of Cardiac Rehabilitation on Functional Capacity, Depression, Quality of Life, and Sleep Quality in Patients With Heart Disease: A Retrospective Study

NCT07468955•Kutahya Health Sciences University

View on ClinicalTrials.gov

Summary

Objective: This study aimed to retrospectively evaluate the impact of cardiac rehabilitation (CR) on functional capacity, depressive symptoms, and the quality of life and sleep in patients with heart disease. Methods: A retrospective analysis was conducted on patients who participated in a structured CR program. Clinical records were reviewed to compare pre- and post-rehabilitation outcomes. Functional capacity was assessed using the 6-Minute Walk Test (6MWT), while depressive symptoms, health-related quality of life, and sleep quality were evaluated using the Beck Depression Inventory (BDI), the Short Form-36 (SF-36), and the Pittsburgh Sleep Quality Index (PSQI), respectively.

Eligibility

Age

30 - 80 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Patients diagnosed with coronary artery disease (CAD), status post-myocardial infarction (MI), stable angina, or those who have undergone cardiac surgery
•Availability of complete pre- and post-rehabilitation clinical records, including 6-Minute Walk Test (6MWT), BDI, SF-36, and PSQI scores.
•Patients classified as stable by a cardiologist prior to the initiation of the exercise program.

Exclusion Criteria

•Presence of severe orthopedic, neurological, or musculoskeletal disorders that prevent the performance of the 6-Minute Walk Test or exercise training.
•Patients with severe cognitive impairment
•Unstable angina pectoris, uncontrolled arrhythmias, or advanced heart failure (NYHA Class IV) that contraindicates aerobic exercise.
•Patients who dropped out of the rehabilitation program before completion or had more than a 20% absence rate in sessions.
•Patients who underwent major non-cardiac surgery within the last 3 months.

Locations (1)

Kutahya Şehir Hastanesi Yoncalı Yerleşkesi

Kütahya, Center, Turkey (Türkiye)

Key Dates

Start Date

July 14, 2019

Primary Completion Date

October 30, 2023

Completion Date

March 8, 2026

Last Updated

March 13, 2026

Enrollment

ACTUAL participants

Conditions

Coronary Artery DiseaseCoronary Heart Disease

Interventions

Exercise Based Cardiac Rehabilitation

OTHER

Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI

NCT05681702

Coronary Artery Disease

View study

RECRUITING

"Erectile Function After PCI in MI and Non-MI Patients"

NCT07444697

Erectile DisfunctionCoronary Artery Disease (CAD)+3 more

View study

RECRUITING

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 13, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Impact of Cardiac Rehabilitation on Patient Outcomes

Inclusion Criteria

Exclusion Criteria

Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI

"Erectile Function After PCI in MI and Non-MI Patients"

Revascularization Strategies in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) and Severe Coronary Artery Disease

Product Surveillance Registry

Essential Pro Study ( rEPIC04E-HK )

Factors Affect Outcomes in Cardiovascular Surgery